Dr Alessandro Pappalardo
Dr Alessandro Pappalardo is an experienced pharmaceutical quality professional with extensive experience in ensuring compliance in the pharmaceutical and healthcare sectors. He holds a Specialist Degree in Pharmacy from the University of Catania (2004-2011), where his thesis focused on the involvement of the opioid system in the central anti-allodynic effects of Substance P. His academic journey continued with a PhD in Molecular Medicine from the same institution (2012-2016), where he studied the role of GABAA receptors on pancreatic alpha cells and their involvement in the desensitisation of FFA in type II diabetes mellitus.
Dr Alessandro Pappalardo’s professional career began as a QC Senior Analyst at Chemi Pharma Ltd in Malta (2017-2018), specialising in aseptically manufactured and terminally sterilised finished products. He then progressed to the role of Head of QC and Responsible Person for Dietary Supplement Production at Pharmex Enterprise Ltd. (2018-2019), where he oversaw solid, semi-solid and liquid dosage forms. From there, he served as Qualified Person and Pharmacist at Pharmadox Healthcare Ltd. (2019-2022) where he ensured compliance for various dosage forms.
Expanding his expertise, Dr Alessandro Pappalardo joined The Force CT GmbH in Germany (2022-2023) as a Qualified Person and Responsible Person, where he set up quality systems for clients, managed GDP and API releases and provided interim management for quality assurance. Most recently, he worked at Panaxia Operations (Malta) Ltd. (2023-2024) as a Qualified Person and Senior Quality Assurance Pharmacist, ensuring compliance with GMP requirements, managing customer and supplier complaints, and overseeing the control and management of cannabis material related to manufacturing.
Currently, Dr Alessandro Pappalardo is a Qualified Person, Responsible Person and Regulatory Affairs Advisor at Pharmaconsulta Ltd in Ta’Xbiex, Malta. In this role, he provides strategic guidance, conducts assays and provides regulatory advice.